Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel iodophor composition and methods of use

A technology of composition and gel composition, which is applied in the field of infection such as

Pending Publication Date: 2019-03-05
VELOCE BIOPHARMA LLC
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0015] There remains a problem in the art of providing topical ophthalmic preparations comprising lower concentrations of gelling agents but maintaining stability and efficacy for a period of time reflected in an acceptable shelf life of the composition

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel iodophor composition and methods of use
  • Novel iodophor composition and methods of use
  • Novel iodophor composition and methods of use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0166] The examples and descriptions provided herein are not intended as and are not intended to be limiting of the scope of protection provided within the full scope and spirit of the invention as described.

[0167] The results of the clinical treatment with the composition according to the invention are shown in Table 14 below:

[0168] Table 14. Clinical characteristics of patients treated with 0.25% PVP-I, 44.0% DMSO, 1.0% HEC and water (pH=3.5) result

[0169]

[0170]

[0171] treatment example

[0172] The following are examples of clinical treatments that can be performed using the compositions of the invention, illustrating the positive clinical responses that can result from such treatments, in young, middle-aged and elderly patients, both male and female, in view of the present Technically, this would be unexpected, but would be predicted based on the demonstrated stability and efficacy of the compositions developed and tested in accordance with the pres...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

Described are stable topical formulations useful in the treatment of viral wart infection, demodex infection and bacterial infection of the skin, and genitalia and the method of treating viral wart infection, demodex infection and bacterial infection of the skin, and genitalia with said compositions.

Description

Background of the invention [0001] Millions of human patients suffer from viral infections or viral wart infections, demodex infections, fungal or yeast infections, or bacterial infections of the skin, including the eyes, eyelids, or the skin around the eyes. [0002] Infections of the eyes or eyelids can occur through direct person-to-person skin contact or indirectly through contaminated surfaces in publicly accessed areas such as public swimming pools or gymnasiums. Exposure to infectious agents can occur through minor abrasions and promote infection through maceration of the epithelium. Autoinoculation is also common. [0003] Verruca vulgaris, the medical term for wart, is used as an umbrella term for all warts. Warts can result from viral infections most commonly associated with human papillomavirus (HPV) or molluscum contagiosum virus (MCV). Nongenital skin warts occur in 20% of schoolchildren with equal frequency in both sexes. [0004] Viral or viral wart infectio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/06A61K47/20A61K33/18A61K31/79A61P27/02A61P31/12A61P33/14
CPCA61K9/0048A61K9/06A61K31/79A61K33/18A61K47/20A61K2300/00A61K47/38
Inventor 约瑟夫·卡普里奥蒂卡拉·卡普里奥蒂杰西·佩尔蒂埃凯文·斯图尔特
Owner VELOCE BIOPHARMA LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com